Fred Perry White Jacket
Dr. Denner brings a strong background overseeing the operations and research and development of healthcare companies and evaluating corporate governance matters. He also has extensive experience as an investor, particularly with respect to healthcare companies, and has broad healthcare industry knowledge.
Investor Seeks Two Board Seats At Ariad Pharmaceuticals, Inc. (ARIA) Biogen Idec, Inc. (Massachusetts) (BIIB) Taps Papadopoulos As Its Chairman, Replacing Young
ARIAD Expands Its Board of Directors with Appointment of Alexander J. of Sarissa Capital Management
"We welcome Dr. Denner to the Company's Board and look forward to working with him to continue building shareholder value, which we all believe is best achieved through successful commercialization of Iclusig(R) (ponatinib), as well as the ongoing development of our strong pipeline of important cancer medicines," Polo Golf Shirts Uk
This press release contains "forward looking statements" including, but not limited to, statements about ARIAD's plans, objectives, expectations and intentions. Such statements include: the continued building of shareholder value through the successful commercialization of Iclusig, the ongoing development of our pipeline of cancer medicines, and the Polo Lacoste Slim Fit
appointment of another independent director. Forward looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. Securities and Exchange Commission. The information contained in this press release is believed to be current as of the date of original issue. The Company does not intend to update any of the forward looking statements after the date of this document to conform these statements to actual results or to changes in the Company's expectations, except as required by law.
Previously, Dr. Denner served as a senior managing director at Icahn Capital, a portfolio manager at Viking Global Investors, and a portfolio manager at Morgan Stanley Investment Management. Dr. Denner serves as a director of Biogen Idec Inc. and VIVUS, Inc., both biopharmaceutical companies.
CAMBRIDGE, Mass. (BUSINESS WIRE) February 21, 2014 ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the appointment of Alexander J. to a two year term on the Company's Board of Directors, effective immediately. With the addition of Dr. Denner, who serves as the chief investment officer and founding partner of Sarissa Capital Management LP, the Board now comprises nine directors, eight of whom are independent. The Company will also appoint another independent director to the Board, who will be selected by the Fred Perry White Jacket Board and be subject to Dr. Denner's concurrence.
Ariad Pharmaceuticals, Inc. (ARIA) Fred Perry T Shirt Blue
Ariad Pharmaceuticals, Inc. (ARIA) And Medinol Ltd. Announce Initiation Of Two Registration Trials Of The Nirsupreme Ridaforolimus Eluting Stent For Use In Coronary Artery Disease Gilead Sciences, Inc. (GILD) Execs Bag Pay Hikes, $8 Million In Bonuses
Ariad Pharmaceuticals Inc Brings In Two Activist Backed Directors Onto Board Of Directors
About Sarissa Capital Management LP
Sarissa Capital Management LP, headquartered in Greenwich, Connecticut, is an investment advisor to private investment funds. Sarissa seeks to achieve superior risk adjusted returns by constructing a portfolio, primarily across healthcare and related sectors, where there is a significant discrepancy between market value and intrinsic value. Sarissa will frequently use activism to close this discrepancy.
Ariad Pharmaceuticals, Inc. (ARIA) To Host Conference Call And Webcast Discussion Of Fourth Quarter And Year End 2013 Financial Results On February 25, 2014 TriCore Reference Laboratories Names New CEO
"I am very pleased by the outcome of our recent discussions with ARIAD. Importantly, the agreement we reached offers the opportunity to immediately work together with the existing Board to maximize the potential of Iclusig and the pipeline of cancer medicines and to build value for all shareholders," said Dr. Denner.
Comes Roaring Back As FDA OKs Bringing Cancer Drug Back To Market; Stock Up +16.49% At Market Close (Dec. 20, 2013) $4.2 Billion Deal Gives ViroPharma Incorporated (VPHM) Execs Huge Paydays
said Harvey J.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult to treat cancers. ARIAD utilizes computational and structural approaches to design small molecule drugs that overcome resistance to existing cancer medicines.
Fred Perry White Jacket
Adidas Long Sleeve Crew NeckHome / Fred Perry White Jacket
Adidas Hoodie Blue And White
Lacoste T Shirt Polo
Adidas Hoodie Girls
Adidas Long Sleeve Red
Adidas Hoodies Pink
Polo T Shirts Online India
Us Polo Shirts Online Shopping India
Fred Perry Polo Dress Black
Lacoste Hoodie Sale
Lacoste Polo Shirts Mens Clothing
Custom Embroidered Polo Shirts Uk
Polo Shirts Black And White
Lacoste Polo T Shirts Sale
Buy Polo T Shirts Online India